What’s in the government’s omnibus spending package

The text of the 4,155-page, $1.7 trillion omnibus spending bill was delivered around ...

otc-narcan-naxolone-opiant-opioid-epidemic

Teen opioid deaths are on the rise – but OTC Narcan could help

It’s no surprise the COVID-19 pandemic aggravated the United States’ already rampant opioid ...

Biden Administration seeks public input on how to support biotech

The federal government today released two calls for public input on how the ...

Mexico proposes amendments to biotech corn ban

On Friday, Mexican officials proposed amendments to the plan to ban imports of ...

BIO aids global harmonization, helping speed cures to patients

The process of holding clinical trials and gaining FDA approval takes up much ...

More parents oppose routine childhood vaccines since 2019, survey shows

One-third of parents now oppose public schools requiring students to get routine childhood ...

A conversation with Fritz Bittenbender, new BIO Board Chair

The exciting new developments we’re seeing in biotechnology must be supported by equally innovative policy, according to Fritz Bittenbender, the new Chair of the Board ...

July 10, 2025

Pennsylvania’s Gov. Shapiro courts biotechs at BIO 2025

June 18, 2025

BIO 2025: Commissioner Martin Makary, M.D., M.P.H., discusses vision for FDA

June 17, 2025

LATEST NEWS

Health

A legacy of love, leadership, and liberation: Tigerlily’s next chapter

October is Breast Cancer Awareness Month, and to mark the occasion, Bio.News has partnered with the Tigerlily Foundation to explore how they developed their advocacy. ...

October 30, 2025

BIO Events

PACE: CDER director discusses faster approval, FDA morale with BIO CEO John F. Crowley

The FDA is hiring reviewers and finding ways to expedite drug approval, Dr. George Tidmarsh, Director of the Food and Drug Administration (FDA) Center for ...

October 29, 2025

BIO Events

BIO PACE 2025: Patients need to ensure state policies enable access to medicine

With Medicaid cuts expected, vaccine hesitancy getting politicized, and the continued challenge of Prescription Drug Affordability Boards (PDABs), state legislatures will drive many of the ...

October 28, 2025

BIO Events

BIO PACE 2025: Why patient advocates are key to the vaccine conversation

The post-COVID era has not been kind to legislation supportive of vaccines, on either the state or the federal level. But advocates have persisted in ...

October 27, 2025

Federal Policy

BIO brings together patient advocates and industry at PACE

With the goal of breaking down barriers so patients can access innovative medicines they need, the Biotechnology Innovation Organization (BIO) is bringing patient advocates together ...

October 27, 2025